Should prenatal chromosomal microarray analysis be offered for isolated fetal growth restriction? A French multicenter study
Authors:
- 1 December 2021
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 225 (6) , 676.e1-676.e15
Abstract
No abstract availableKeywords
Funding Information
- Agence de la Biomédecine
This publication has 43 references indexed in Scilit:
- Fetal aortic wall thickness: a marker of hypertension in IUGR children?Hypertension Research, 2013
- Chromosomal Microarray versus Karyotyping for Prenatal DiagnosisNew England Journal of Medicine, 2012
- Experience with microarray‐based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnanciesPrenatal Diagnosis, 2012
- Clinical utility of array comparative genomic hybridisation for prenatal diagnosis: a cohort study of 3171 pregnanciesBJOG: An International Journal of Obstetrics & Gynaecology, 2012
- Introducing array comparative genomic hybridization into routine prenatal diagnosis practice: a prospective study on over 1000 consecutive clinical casesPrenatal Diagnosis, 2011
- Array CGH analysis in high‐risk pregnancies: comparing DNA from cultured cells and cell‐free fetal DNAPrenatal Diagnosis, 2011
- American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variantsGenetics in Medicine, 2011
- Use of array comparative genomic hybridization for prenatal diagnosis of fetuses with sonographic anomalies and normal metaphase karyotypePrenatal Diagnosis, 2009
- Infant neurodevelopment following fetal growth restriction: relationship with antepartum surveillance parametersUltrasound in Obstetrics & Gynecology, 2008
- Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 casesPrenatal Diagnosis, 2008